---
title: "RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298666548.md"
description: "RBC Capital analyst Trung Huynh reaffirmed a Hold rating on Bristol-Myers Squibb (BMY) with a $64 price target, noting the stock closed at $64.41. This contrasts with the broader analyst consensus of a Moderate Buy and an average target of $66.83. Additionally, HSBC maintained its Hold rating on BMY with a $65 target."
datetime: "2026-09-11T01:45:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298666548.md)
  - [en](https://longbridge.com/en/news/298666548.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298666548.md)
generator: "portal-rs"
---

# RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)

In a report released on September 9, Trung Huynh from RBC Capital maintained a Hold rating on Bristol-Myers Squibb, with a price target of $64.00. The company’s shares closed yesterday at $64.41.

Huynh covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and AbbVie. According to TipRanks, Huynh has an average return of 22.2% and a 74.66% success rate on recommended stocks. 

Currently, the analyst consensus on Bristol-Myers Squibb is a Moderate Buy with an average price target of $66.83, implying a 3.76% upside from current levels. In a report released yesterday, HSBC also maintained a Hold rating on the stock with a $65.00 price target.

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [00005.HK](https://longbridge.com/en/quote/00005.HK.md)
- [HSBC.US](https://longbridge.com/en/quote/HSBC.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [DTIW.SG](https://longbridge.com/en/quote/DTIW.SG.md)
- [HSBA.UK](https://longbridge.com/en/quote/HSBA.UK.md)

## Related News & Research

- [Bristol Myers Swoons on Test Results](https://longbridge.com/en/news/298335284.md)
- [BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM](https://longbridge.com/en/news/298442546.md)
- [Nike Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts](https://longbridge.com/en/news/300017884.md)
- [Micron Stock Price Forecast — How Much Upside Do Top Analysts Expect in One Year from Today?](https://longbridge.com/en/news/300060079.md)
- [McDonald’s Maps Out Its Next Act, but Analysts See Bumpy Road Ahead](https://longbridge.com/en/news/300062765.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**